The Impact of COMT-inhibition on Gastrointestinal Levodopa Absorption in Patients With Parkinson’s Disease
Clinical Medicine Insights: Therapeutics - New Zealand
doi 10.4137/cmt.s1169
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2010
Authors
Publisher
SAGE Publications